X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (18105) 18105
Book Review (4194) 4194
Newsletter (1022) 1022
Publication (749) 749
Newspaper Article (354) 354
Book Chapter (210) 210
Book / eBook (202) 202
Magazine Article (87) 87
Conference Proceeding (69) 69
Trade Publication Article (13) 13
Transcript (12) 12
Dissertation (10) 10
Web Resource (4) 4
Government Document (2) 2
Paper (2) 2
Reference (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14370) 14370
humans (14163) 14163
female (7442) 7442
male (6844) 6844
pulmonary embolism (6458) 6458
middle aged (5618) 5618
aged (5025) 5025
pulmonary embolism - prevention & control (4783) 4783
risk factors (4558) 4558
adult (4406) 4406
pulmonary-embolism (3812) 3812
thromboembolism (3772) 3772
prevention (3577) 3577
venous thromboembolism (3531) 3531
abridged index medicus (3396) 3396
deep-vein thrombosis (3130) 3130
anticoagulants - therapeutic use (3059) 3059
surgery (3054) 3054
thrombosis (2470) 2470
pulmonary embolism - etiology (2436) 2436
peripheral vascular disease (2180) 2180
treatment outcome (2076) 2076
aged, 80 and over (1996) 1996
hematology (1917) 1917
anticoagulants (1908) 1908
retrospective studies (1865) 1865
medicine, general & internal (1828) 1828
venous thrombosis - prevention & control (1759) 1759
mortality (1747) 1747
research (1746) 1746
cardiac & cardiovascular systems (1684) 1684
postoperative complications - prevention & control (1656) 1656
care and treatment (1633) 1633
venous thrombosis (1615) 1615
risk (1591) 1591
molecular-weight heparin (1543) 1543
diagnosis (1522) 1522
prophylaxis (1470) 1470
deep vein thrombosis (1372) 1372
venous thromboembolism - prevention & control (1358) 1358
respiratory system (1356) 1356
medicine & public health (1334) 1334
incidence (1333) 1333
heparin - therapeutic use (1279) 1279
health aspects (1278) 1278
time factors (1278) 1278
prospective studies (1242) 1242
pulmonary embolism - diagnosis (1237) 1237
venous thrombosis - etiology (1189) 1189
analysis (1186) 1186
adolescent (1181) 1181
risk-factors (1174) 1174
anticoagulants - administration & dosage (1131) 1131
pulmonary embolism - epidemiology (1114) 1114
risk assessment (1114) 1114
pulmonary embolism - drug therapy (1112) 1112
thromboembolism - prevention & control (1061) 1061
medical research (1037) 1037
management (1027) 1027
deep venous thrombosis (1003) 1003
vena cava filters (999) 999
drug therapy (988) 988
recurrence (977) 977
follow-up studies (976) 976
heparin (969) 969
cancer (957) 957
medicine, experimental (934) 934
heparin, low-molecular-weight - therapeutic use (927) 927
anticoagulants - adverse effects (914) 914
animals (911) 911
complications (897) 897
venous thromboembolism - etiology (878) 878
thrombophlebitis - prevention & control (859) 859
patients (850) 850
embolisms (847) 847
prognosis (836) 836
pregnancy (832) 832
venous thrombosis - epidemiology (798) 798
warfarin (798) 798
orthopedics (795) 795
thromboprophylaxis (774) 774
pulmonary arteries (768) 768
therapy (757) 757
venous thromboembolism - epidemiology (757) 757
health risk assessment (747) 747
young adult (747) 747
embolism (730) 730
fibrinolytic agents - therapeutic use (723) 723
pulmonary embolism - mortality (713) 713
cardiology (703) 703
venous thrombosis - drug therapy (682) 682
internal medicine (674) 674
stroke (658) 658
pulmonary embolism - diagnostic imaging (653) 653
pulmonary embolism - therapy (651) 651
hemorrhage - chemically induced (649) 649
disease (641) 641
acute disease (638) 638
anticoagulation (637) 637
heparin - administration & dosage (637) 637
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (158) 158
West Park Healthcare Centre - Stacks (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Online Resources - Online (4) 4
Providence Healthcare - Stacks (4) 4
Scarborough Hospital - General (3) 3
Humber River Regional Hospital - Church Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Toronto East General Hospital - Stacks (2) 2
West Park Healthcare Centre - Archives (2) 2
Baycrest Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Not Returned (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17942) 17942
German (611) 611
French (463) 463
Japanese (175) 175
Russian (172) 172
Spanish (165) 165
Italian (126) 126
Czech (54) 54
Polish (48) 48
Chinese (35) 35
Korean (24) 24
Portuguese (24) 24
Turkish (24) 24
Danish (18) 18
Hungarian (18) 18
Dutch (17) 17
Swedish (14) 14
Finnish (12) 12
Norwegian (11) 11
Croatian (10) 10
Ukrainian (10) 10
Romanian (8) 8
Hebrew (7) 7
Serbian (6) 6
Bulgarian (5) 5
Slovak (3) 3
Bosnian (2) 2
Slovenian (2) 2
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 4, pp. 675 - 682.e8
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 12, pp. 1536 - 1544
Abstract Background The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. Objectives This study investigated the long-term... 
Cardiovascular | Internal Medicine | chronic thromboembolic pulmonary hypertension | thrombolysis | long-term survival | pulmonary embolism | prognosis | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | CARDIOLOGY ESC | EUROPEAN-SOCIETY | TIME TRENDS | TRIAL | TASK-FORCE | HYPERTENSION | Pulmonary Embolism - prevention & control | Echocardiography | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Pulmonary Embolism - mortality | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Tenecteplase | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Stroke (Disease) | Medicine, Experimental | Medical research | Cardiology | Cardiovascular agents | Heart | Therapy | Chest | Lung | Incidence | Design | Computed tomography | Motivation | Tomography | Diagnosis | Thromboembolism | Anticoagulants | Pulmonary arteries | Mortality | Statistical tests | Patients | Fibrinolysis | Survival | Computation | Diagnostic software | Death | Health risk assessment | Risk management | Angiography | Arches | Embolisms | Medical services | Clinical trials | Population studies | Hemorrhage | Bleeding | Guidelines | Reperfusion | Risk assessment | Calcium-binding protein | Trends | Heart diseases | Injuries | Hypertension | Collapse | Stroke | Statistical analysis | Receiving | Steering | Complications | Risk reduction | Statistics | Pulmonary hypertension | Embolism | Computer programs | Contact | Thromboplastin | Medical prognosis | Fatalities | Ventricle | Heparin | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e351S - e418S
Background: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This... 
SPIRAL CT VENOGRAPHY | CASE-FATALITY RATES | MAGNETIC-RESONANCE VENOGRAPHY | SERIAL IMPEDANCE PLETHYSMOGRAPHY | RESPIRATORY SYSTEM | ACUTE VENOUS THROMBOSIS | DEEP-VEIN THROMBOSIS | SUSPECTED PULMONARY-EMBOLISM | D-DIMER LEVELS | TIME COMPRESSION ULTRASONOGRAPHY | COLOR DOPPLER ULTRASOUND | CRITICAL CARE MEDICINE | Predictive Value of Tests | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Tomography, X-Ray Computed - methods | Male | Hemorrhage - prevention & control | Fibrinolytic Agents - adverse effects | Societies, Medical | Fibrinolytic Agents - therapeutic use | Adult | Female | Magnetic Resonance Angiography - methods | Venous Thrombosis - prevention & control | Thrombosis - prevention & control | Ultrasonography - methods | Venous Thrombosis - drug therapy | Fibrin Fibrinogen Degradation Products - analysis | Risk Factors | Probability | Phlebography - methods | Hemorrhage - blood | Evidence-Based Medicine | Ambulatory Care | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Thrombosis - drug therapy | Hemorrhage - chemically induced | Thrombosis - diagnosis | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article